Immunitybio Inc (IBRX)

CapEx to Revenue

4.45%

TTM · Retrieved:

IBRX logo

IBRX CapEx to Revenue

Current (TTM)4.45%
IBRX CapEx/Revenue (0.50% → 4.45%)
High-resolution chart · PNG

IBRX capex to revenue history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Immunitybio Inc CapEx to Revenue — Annual fiscal periods
Period endingCapEx to Revenue
3.3949%
46.7141%
4,917.0418%
32,567.5%
3,593.469%
275.8678%
9,969.7674%
27,876.5957%
77,366.6667%
14,909.0909%
949.5763%
46.6459%
0.5%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.